N4 Pharma PLC (N4P)

Currency in GBP
0.450
0.000(0.00%)
Closed·
N4P Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
N4P is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.4000.500
52 wk Range
0.3500.800
Key Statistics
Bid/Ask
0.40 / 0.50
Prev. Close
0.45
Open
0.45
Day's Range
0.4-0.5
52 wk Range
0.35-0.8
Volume
352.26K
Average Volume (3m)
1.5M
1-Year Change
-14.29%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
N4P Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in overbought territory

N4 Pharma PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

N4 Pharma PLC Company Profile

N4 Pharma Plc, a specialist pharmaceutical company, develops nanoparticle silica delivery systems to enhance the cellular delivery and potency of cancer treatments and vaccines in the United Kingdom. It develops Nuvec, a silica nanoparticle delivery system, which has an irregular surface structure that traps and protects siRNA/RNA/DNA; and Liptide, a platform to deliver a proprietary siRNA sequence to silence a fibrotic gene. The company also engages in the development of N4 101, an orally delivered inflammation inhibitor which is in the pre-clinical development for treatment of inflammatory bowel disease; and ECP105 for the prevention of ocular scarring. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.

Compare N4P to Peers and Sector

Metrics to compare
N4P
Peers
Sector
Relationship
P/E Ratio
−3.5x−2.4x−0.5x
PEG Ratio
−0.09−0.020.00
Price/Book
5.8x1.7x2.6x
Price / LTM Sales
514.3x2.5x3.3x
Upside (Analyst Target)
-61.5%43.5%
Fair Value Upside
Unlock16.1%6.9%Unlock

Earnings

Latest Release
Jun 06, 2025
EPS / Forecast
-- / --
Revenue / Forecast
3.38K / --
EPS Revisions
Last 90 days

N4P Income Statement

FAQ

What Stock Exchange Does N4 Pharma Trade On?

N4 Pharma is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for N4 Pharma?

The stock symbol for N4 Pharma is "N4P."

What Is the N4 Pharma Market Cap?

As of today, N4 Pharma market cap is 4.16M.

What Is N4 Pharma's Earnings Per Share (TTM)?

The N4 Pharma EPS (TTM) is -0.00.

When Is the Next N4 Pharma Earnings Date?

N4 Pharma will release its next earnings report on 16 Sept 2025.

From a Technical Analysis Perspective, Is N4P a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has N4 Pharma Stock Split?

N4 Pharma has split 1 times.

How Many Employees Does N4 Pharma Have?

N4 Pharma has 4 employees.

What is the current trading status of N4 Pharma (N4P)?

As of 07 Aug 2025, N4 Pharma (N4P) is trading at a price of 0.45, with a previous close of 0.45. The stock has fluctuated within a day range of 0.40 to 0.50, while its 52-week range spans from 0.35 to 0.80.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.